Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments
IT
Archived
•
January 9, 2026
•
Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases.
Source: https://www.wired.com/feed/rss - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



